26815-13-4 Usage
General Description
3-[3-(Dimethylamino)propoxy]benzaldehyde, also known as AMPSO Formaldehyde, is an organic compound with the molecular formula C13H19NO2. It is a pale yellow liquid that is commonly used as an intermediate in the synthesis of pharmaceuticals and other chemicals. 3-[3-(Dimethylamino)propoxy]benzaldehyde is often utilized as a key building block in the production of various organic compounds, including dyes, perfumes, and agricultural chemicals. Its chemical structure contains a benzene ring with a aldehyde group and a propoxy group, as well as a dimethylamino group, which gives it its unique chemical properties. AMPSO Formaldehyde typically has a strong, aromatic odor and is considered to be a hazardous chemical, requiring careful handling and storage.
Check Digit Verification of cas no
The CAS Registry Mumber 26815-13-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,6,8,1 and 5 respectively; the second part has 2 digits, 1 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 26815-13:
(7*2)+(6*6)+(5*8)+(4*1)+(3*5)+(2*1)+(1*3)=114
114 % 10 = 4
So 26815-13-4 is a valid CAS Registry Number.
InChI:InChI=1/C12H17NO2/c1-13(2)7-4-8-15-12-6-3-5-11(9-12)10-14/h3,5-6,9-10H,4,7-8H2,1-2H3
26815-13-4Relevant articles and documents
Design and synthesis of benzylpiperidine inhibitors targeting the menin–MLL1 interface
Ren, Jing,Xu, Wei,Tang, Le,Su, Minbo,Chen, Danqi,Chen, Yue-Lei,Zang, Yi,Li, Jia,Shen, Jingkang,Zhou, Yubo,Xiong, Bing
supporting information, p. 4472 - 4476 (2016/08/25)
Menin is an essential oncogenic cofactor for mixed lineage leukemia (MLL)-mediated leukemogenesis, functioning through its direct interaction with MLL1 protein. Therefore, targeting the menin–MLL1 protein–protein interface represents a promising strategy
Aryl-substituted benzimidazole and imidazopyridine ethers
-
Page/Page column 14, (2010/02/15)
Aryl substituted benzimidazole and imidazo[4,5]pyridine ethers are described as inhibitors of Cds1 and useful as adjuvants to chemotherapy or radiation therapy in the treatment of cancer.
CNS active compounds
-
, (2008/06/13)
Compounds of the formula SPC1 Wherein X, R, n and B are as defined herein exhibit antidepressant activity.
